ArticleOncotarget2016

Therapeutic efficacy of the bromodomain inhibitor OTX015/MK-8628 in ALK-positive anaplastic large cell lymphoma: an alternative modality to overcome resistant phenotypes.

Michela Boi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.